<DOC>
	<DOCNO>NCT02006342</DOCNO>
	<brief_summary>To determine co-administration subcutaneous ( SQ ) Insulin glargine combination intravenous ( IV ) insulin decrease time resolution ketoacidosis requirement ICU admission compare IV insulin delay administration SQ glargine treatment DKA .</brief_summary>
	<brief_title>Effectiveness Subcutaneous Glargine On The Time To Closure The Anion Gap Patients Presenting Emergency Department With Diabetic Keto-acidosis</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Age &gt; 18 year Blood Glucose &gt; 200 pH &lt; 7.3 Bicarbonate &lt; 18 Ketonemia Ketonuria Anion Gap &gt; = 16 Age &lt; 18 year Pregnant ESRD Prisoners Patients shock require emergency surgery Those unwilling consent trial Allergic Insulin Glargine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetic Ketoacidosis</keyword>
	<keyword>Insulin Glargine</keyword>
	<keyword>Anion gap</keyword>
	<keyword>Metabolic acidosis</keyword>
</DOC>